U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375498) titled 'Phase 1 Clinical Study of the Safety and Pharmacokinetics of Rescue Liposome in Healthy Adult Participants' on Jan. 13.

Brief Summary: This is a Phase 1 study to assess the safety and tolerability of the liposomal product in healthy participants.

Study Start Date: Aug. 20, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Adult Overdose Antidote

Intervention: DRUG: liposome dispersion

liposome rescue

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Cristalia Produtos Quimicos Farmaceuticos Ltda.

Disclaimer: Curated by HT Syndication....